Insider · CIK 0001657765
Kyle Moran
Files at WVE (Wave Life Sciences Ltd.). First filing Dec 10, 2025, latest Feb 11, 2026.
In brief
Kyle Moran files SEC Form 4 as CFO at WVE (Wave Life Sciences Ltd.). Since Dec 10, 2025, Kyle Moran has reported 0 open-market buys worth $0 and 2 open-market sells worth $4.2M, the latest filed on Feb 11, 2026.
A track record needs three past buys with six months of prices behind them; Kyle Moran has 0, so none is measured yet.
The newest scored trade: sold $48k of WVE on Feb 9, 2026, filed Feb 11, 2026, scored 44 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $4.2M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WVE: Wave Life Sciences Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Wave Life Sciences Ltd. | $48k 3,588 shares | -3% | +149% from low-36% from high | |
| 47Moderate | Wave Life Sciences Ltd. | $4.1M 260,036 shares | -174% | +238% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 9, 2026 | WVE Wave Life Sciences Ltd. | 3,564 0.00% of outstanding | $48k | Feb 9, 2026 | $4.8M |
| Dec 9, 2025 | WVE WAVE LIFE SCIENCES LTD. | 86,000 0.05% of outstanding | $1.6M | Dec 9, 2025 | $3.1M |
| Dec 8, 2025 | WVE WAVE LIFE SCIENCES LTD. | 210,000 0.13% of outstanding | $1.6M | Dec 8, 2025 | none |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | WVE Wave Life Sciences Ltd. | AGrant or award Ordinary Shares | +45,625 | $0.00 | $0 | 137,973 | Feb 11, 2026 |
| Feb 9, 2026 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares | -3,588 | $13.45 | $48k | 134,385 | Feb 11, 2026 |
| Feb 5, 2026 | WVE Wave Life Sciences Ltd. | AGrant or award Share Option (right to buy)derivative | +273,750 | $0.00 | $0 | 273,750 | Feb 11, 2026 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | MOption exercise Ordinary Shares10b5-1 | +60,000 | $2.83 | $170k | 149,218 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares10b5-1 | -60,000 | $13.20 | $792k | 89,218 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | MOption exercise Ordinary Shares10b5-1 | +100,000 | $3.14 | $314k | 189,218 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares10b5-1 | -50,000 | $15.00 | $750k | 139,218 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares10b5-1 | -50,000 | $13.20 | $660k | 89,218 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | MOption exercise Ordinary Shares10b5-1 | +50,000 | $4.75 | $238k | 139,218 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares10b5-1 | -50,000 | $18.00 | $900k | 89,218 | Dec 10, 2025 |
| Dec 9, 2025 | WVE Wave Life Sciences Ltd. | MOption exercise Ordinary Shares10b5-1 | +36,000 | $8.17 | $294k | 125,218 | Dec 10, 2025 |
| Dec 9, 2025 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares10b5-1 | -36 | $20.25 | $729 | 89,218 | Dec 10, 2025 |
| Dec 9, 2025 | WVE Wave Life Sciences Ltd. | MOption exercise Ordinary Shares10b5-1 | +50,000 | $10.48 | $524k | 139,218 | Dec 10, 2025 |
| Dec 9, 2025 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares10b5-1 | -50,000 | $20.03 | $1.0M | 90,365 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | AGrant or award Share Option (right to buy)derivative10b5-1 | -60,000 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | AGrant or award Share Option (right to buy)derivative10b5-1 | -100,000 | $0.00 | $0 | 75,000 | Dec 10, 2025 |
| Dec 8, 2025 | WVE Wave Life Sciences Ltd. | AGrant or award Share Option (right to buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 222,700 | Dec 10, 2025 |
| Dec 9, 2025 | WVE Wave Life Sciences Ltd. | AGrant or award Share Option (right to buy)derivative10b5-1 | -36,000 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Dec 9, 2025 | WVE Wave Life Sciences Ltd. | AGrant or award Share Option (right to buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 0 | Dec 10, 2025 |
| Oct 11, 2024 | WVE Wave Life Sciences Ltd. | MOption exercise Ordinary Shares | +25,000 | $2.48 | $62k | 44,777 | Oct 11, 2024 |
| Oct 11, 2024 | WVE Wave Life Sciences Ltd. | MOption exercise Share Option (right to buy)derivative | -25,000 | $0.00 | $0 | 0 | Oct 11, 2024 |
Questions about Kyle Moran
Answered from the filings on this page, as of the latest one.
Is Kyle Moran buying or selling?
In the last 12 months Kyle Moran reported 0 open-market buys worth $0 and 2 open-market sells worth $4.2M on SEC Form 4; the latest was sold $48k of WVE on Feb 9, 2026. Grants, option exercises and tax withholding are not counted.
How did Kyle Moran's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kyle Moran has 0.
Where does Kyle Moran file Form 4?
Kyle Moran has filed Form 4 at WVE (Wave Life Sciences Ltd.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.